Global Pharmaceutical Intermediates Market

Pharmaceutical Intermediates Market Size, Share, Growth Analysis, By Product (Chemical Intermediates, Bulk Drug Intermediates), By Category (Branded Drug Intermediates, Generic Drug Intermediates), By Application (Analgesics, Anti-Inflammatory Drug), By End User (Biotech And Pharma Companies, Research Laboratory), By Region - Industry Forecast 2025-2032

Report ID: SQMIG35I2111 | Region: Global | Published Date: December, 2024
Pages: 157 | Tables: 65 | Figures: 75

Pharmaceutical Intermediates Market Competitive Landscape

Global pharmaceutical intermediates market is highly competitive with the presence of local as well as global companies. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of global pharmaceutical intermediates market.

Pharmaceutical Intermediates Market Top Player's Company Profiles

  • BASF SE (Germany) 
  • Sanofi SA (France) 
  • Thermo Fisher Scientific Inc. (US) 
  • Merck KGaA (Germany) 
  • Dishman Carbogen Amcis Ltd. (India) 
  • Evonik Industries AG (Germany) 
  • Arkema Inc. (France) 
  • Lonza Group AG (Switzerland) 
  • Wuxi AppTec Co., Ltd. (China) 
  • Aurobindo Pharma Limited (India) 
  • Lianhe Chemical Technology Co., Ltd. (China) 
  • Cambrex Corporation (US) 
  • Vertellus Holdings LLC (US) 
  • Hovione LLC (Portugal) 
  • Hikal Ltd. (India) 
  • Codexis Inc. (US) 
  • Aceto Corporation (US) 
  • Interchem Corporation (US) 
  • Midas Pharma GmbH (Germany) 
  • Arbiom (US) 

Pharmaceutical Intermediates Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Pharmaceutical Intermediates Market size was valued at USD 32.53 Billion in 2023 and is poised to grow from USD 34.58 Billion in 2024 to USD 56.37 Billion by 2032, growing at a CAGR of 6.30% during the forecast period (2025-2032).

Global pharmaceutical intermediates market is highly competitive with the presence of local as well as global companies. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of global pharmaceutical intermediates market. 'BASF SE (Germany) ', 'Sanofi SA (France) ', 'Thermo Fisher Scientific Inc. (US) ', 'Merck KGaA (Germany) ', 'Dishman Carbogen Amcis Ltd. (India) ', 'Evonik Industries AG (Germany) ', 'Arkema Inc. (France) ', 'Lonza Group AG (Switzerland) ', 'Wuxi AppTec Co., Ltd. (China) ', 'Aurobindo Pharma Limited (India) ', 'Lianhe Chemical Technology Co., Ltd. (China) ', 'Cambrex Corporation (US) ', 'Vertellus Holdings LLC (US) ', 'Hovione LLC (Portugal) ', 'Hikal Ltd. (India) ', 'Codexis Inc. (US) ', 'Aceto Corporation (US) ', 'Interchem Corporation (US) ', 'Midas Pharma GmbH (Germany) ', 'Arbiom (US) '

The constantly increasing incidences of chronic diseases, as well as the aging population worldwide, are major factors that are expected to increase the need for drug formulations for the management of chronic diseases. According to the World Health Organization (WHO), the incidence of diabetes has increased from 108.0 million in 1980 to 422.0 million in 2014, and this number continues to rise. Also, according to the World Health Organization (WHO), the incidence of chronic diseases is expected to increase by 57% by 2020, indicating that a significant percentage of the population is suffering from chronic diseases. All these factors are driving the growth of the market during the forecast period.

The cost of heart disease to the nation's health care system is increasing. A key trend in the pharmaceutical intermediates market is the rise in chronic cardiovascular conditions such as heart failure and coronary artery disease. According to a paper published in July 2020 in the Curious Journal of Medical Science, ischemic heart disease (IHD) is the leading cause of death worldwide. Ischemic heart disease affects about 126 million people globally. It is expected that by 2030, there will be more than 1,845 cases of ischemic heart disease per 100,000 persons worldwide.

On the basis of region, global pharmaceutical intermediates market is divided into North America, Europe, Asia Pacific, Latin America, and MEA. North America dominated the global pharmaceutical intermediates market and is expected to maintain its dominance during the forecast period. North America is dominating the market due to the presence of various pharmaceutical companies, research centres, and laboratories, and rapidly growing CMOs & CROs in the US and Canada. Also, rising investments by the government and private players to boost the growth of the market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Active Pharmaceutical Ingredients (API) Market
Buy Now GET FREE SAMPLE
Pharmaceuticals Market
Buy Now GET FREE SAMPLE
Compounding Pharmacy Market
Buy Now GET FREE SAMPLE
Pharmaceutical Manufacturing Market
Buy Now GET FREE SAMPLE
Pharmaceutical Processing Equipment Market
Buy Now GET FREE SAMPLE
Pharmaceutical Excipients Market
Buy Now GET FREE SAMPLE
Pharmaceutical Isolator Market
Buy Now GET FREE SAMPLE
Pharmaceutical Robots Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Pharmaceutical Intermediates Market

Report ID: SQMIG35I2111

$5,300
BUY NOW GET FREE SAMPLE